Abstract
Global Noninvasive Prenatal Diagnostics Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Noninvasive Prenatal Diagnostics market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026.
Noninvasive Prenatal Diagnostics Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
By geography, this market has been segregated into five regions with revenue and growth rate of Noninvasive Prenatal Diagnostics from 2013 to 2026,
• North America (U.S., Canada, Mexico)
• Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
• Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
• Latin America (Brazil, Rest of L.A.)
• Middle East And Africa(Turkey, GCC, Rest of Middle East)
The major players operating into Noninvasive Prenatal Diagnostics Market include:
Natera
Illumina
BGI Diagnosis
Ariosa Diagnostics
Quest Diagnostics
Premaitha Health
NIPD Genetics
Labcorp
Ravgen
LifeCodexx
TrovaGene
Quest Diagnostics
Berry Genomics
This report segments the Global Noninvasive Prenatal Diagnostics Market as follows:
Global Noninvasive Prenatal Diagnostics Market: Type Segment Analysis
Services
Instrument
Global Noninvasive Prenatal Diagnostics Market: Application Segment Analysis
Hospital
Personal
Other
There are 13 chapters to put on view for Noninvasive Prenatal Diagnostics Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
Chapter 2: Market competition by Manufacturers
Chapter 3: Production by Regions
Chapter 4: Consumption by Regions
Chapter 5: Production, By Types, Revenue and Market share by Types
Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications
Chapter 7: Complete profiling and analysis of Manufacturers
Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast
Chapter 13: Noninvasive Prenatal Diagnostics Research Findings and Conclusion, Appendix, methodology and data source
Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report.
Industry Chain Analysis
Raw Material and Suppliers
Equipment and Suppliers
Manufacturing Process
Manufacturing Cost Structure
Manufacturing Plants Distribution Analysis
Available Customizations
We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview
1.1 Noninvasive Prenatal Diagnostics Market Overview
1.1.1 Noninvasive Prenatal Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Noninvasive Prenatal Diagnostics Market Size and Analysis by Regions (2014-2019)
1.2.1 North America Noninvasive Prenatal Diagnostics Market Status and Outlook
1.2.2 EU Noninvasive Prenatal Diagnostics Market Status and Outlook
1.2.3 Japan Noninvasive Prenatal Diagnostics Market Status and Outlook
1.2.4 China Noninvasive Prenatal Diagnostics Market Status and Outlook
1.2.5 India Noninvasive Prenatal Diagnostics Market Status and Outlook
1.2.6 Southeast Asia Noninvasive Prenatal Diagnostics Market Status and Outlook
1.3 Global Noninvasive Prenatal Diagnostics Market Segment by Types (2014-2025)
1.3.1 Global Noninvasive Prenatal Diagnostics Revenue and Growth Rate Comparison by Types (2014-2025)
1.3.2 Global Noninvasive Prenatal Diagnostics Revenue Market Share by Types in 2018
1.3.3 Services
1.3.4 Instrument
1.3.5 Type 3
Others
1.4 Noninvasive Prenatal Diagnostics Market by End Users/Application
1.4.1 Global Noninvasive Prenatal Diagnostics Revenue (USD Mn) Comparison by Applications (2014-2025)
1.4.1 Hospital
1.4.2 Personal
1.4.3 Other
Others
Chapter 2 Global Noninvasive Prenatal Diagnostics Competition Analysis by Players
2.1 Global Noninvasive Prenatal Diagnostics Market Size (Million USD) by Players (2014-2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
Chapter 3 Company (Top Players) Profiles and Key Data
3.1 Natera
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Natera, Noninvasive Prenatal Diagnostics Revenue (Million USD) (2014-2019)
3.1.5 Recent Developments
3.2 Illumina
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Illumina, Noninvasive Prenatal Diagnostics Revenue (Million USD) (2014-2019)
3.2.5 Recent Developments
3.3 BGI Diagnosis
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 BGI Diagnosis, Noninvasive Prenatal Diagnostics Revenue (Million USD) (2014-2019)
3.3.5 Recent Developments
3.4 Ariosa Diagnostics
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Ariosa Diagnostics, Noninvasive Prenatal Diagnostics Revenue (Million USD) (2014-2019)
3.4.5 Recent Developments
3.5 Quest Diagnostics
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Quest Diagnostics, Noninvasive Prenatal Diagnostics Revenue (Million USD)(2014-2019)
3.5.5 Recent Developments
3.6 Premaitha Health
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Premaitha Health, Noninvasive Prenatal Diagnostics Revenue (Million USD)(2014-2019)
3.6.5 Recent Developments
3.7 NIPD Genetics
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 NIPD Genetics, Noninvasive Prenatal Diagnostics Revenue (Million USD)(2014-2019)
3.7.5 Recent Developments
3.8 Labcorp
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Labcorp, Noninvasive Prenatal Diagnostics Revenue (Million USD) (2014-2019)
3.8.5 Recent Developments
3.9 Ravgen
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Ravgen, Noninvasive Prenatal Diagnostics Revenue (Million USD) (2014-2019)
3.9.5 Recent Developments
3.10 LifeCodexx
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 LifeCodexx, Noninvasive Prenatal Diagnostics Revenue (Million USD) (2014-2019)
3.10.5 Recent Developments
Chapter 4 Global Noninvasive Prenatal Diagnostics Market Size Type (2014-2019)
4.1 Global Noninvasive Prenatal Diagnostics Market Size by Type (2014-2019)
Chapter 5 Global Noninvasive Prenatal Diagnostics Market Size Application (2014-2019)
5.1 Global Noninvasive Prenatal Diagnostics Market Size by Application (2014-2019)
5.2 Potential Application of Noninvasive Prenatal Diagnostics in Future
5.3 Top Consumer / End Users of Noninvasive Prenatal Diagnostics
Chapter 6 North America Noninvasive Prenatal Diagnostics Development Status and Outlook
6.1 North America Noninvasive Prenatal Diagnostics Market Size (2014-2019)
6.2 North America Noninvasive Prenatal Diagnostics Market Size by Application (2014-2019)
Chapter 7 EU Noninvasive Prenatal Diagnostics Development Status and Outlook
7.1 EU Noninvasive Prenatal Diagnostics Market Size (2014-2019)
7.2 EU Noninvasive Prenatal Diagnostics Market Size by Application (2014-2019)
Chapter 8 Japan Noninvasive Prenatal Diagnostics Development Status and Outlook
8.1 Japan Noninvasive Prenatal Diagnostics Market Size (2014-2019)
8.2 Japan Noninvasive Prenatal Diagnostics Market Size by Application (2014-2019)
Chapter 9 China Noninvasive Prenatal Diagnostics Development Status and Outlook
9.1 China Noninvasive Prenatal Diagnostics Market Size and Forecast (2014-2019)
9.2 China Noninvasive Prenatal Diagnostics Market Size by Application (2014-2019)
Chapter 10 India Noninvasive Prenatal Diagnostics Development Status and Outlook
10.1 India Noninvasive Prenatal Diagnostics Market Size and Forecast (2014-2019)
10.2 India Noninvasive Prenatal Diagnostics Market Size by Application (2014-2019)
Chapter 11 Southeast Asia Noninvasive Prenatal Diagnostics Development Status and Outlook
11.1 Southeast Asia Noninvasive Prenatal Diagnostics Market Size and Forecast (2014-2019)
11.2 Southeast Asia Noninvasive Prenatal Diagnostics Market Size by Application (2014-2019)
Chapter 12 Market Forecast by Regions and Application (2019-2025)
12.1 Global Noninvasive Prenatal Diagnostics Market Size (Million USD) by Regions (2019-2025)
12.1. North America Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2019-2025)
12.1.2 EU Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2019-2025)
12.1.3 China Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2019-2025)
12.1.4 Japan Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2019-2025)
12.1.5 Southeast Asia Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2019-2025)
12.1.6 India Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2019-2025)
12.2 Global Noninvasive Prenatal Diagnostics Market Size by Application (2019-2025)
Chapter 13 Noninvasive Prenatal Diagnostics Market Dynamics
13.1 Noninvasive Prenatal Diagnostics Market Opportunities
13.2 Noninvasive Prenatal Diagnostics Challenge and Risk
13.2.1 Competition from Opponents
13.2.2 Downside Risks of Economy
13.3 Noninvasive Prenatal Diagnostics Market Constraints and Threat
13.3.1 Threat from Substitute
13.3.2 Government Policy
13.3.3 Technology Risks
13.4 Noninvasive Prenatal Diagnostics Market Driving Force
13.4.1 Growing Demand from Emerging Markets
13.4.2 Potential Application
Chapter 14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs Trend/Customer Preference
14.3 External Environmental Change
14.3.1 Economic Fluctuations
14.3.2 Other Risk Factors
Chapter 15 Research Finding /Conclusion
Chapter 16 Methodology and Data Source
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
16.4 Author List
